rs2646264

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004369.4(COL6A3):​c.6930+43G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 1,593,010 control chromosomes in the GnomAD database, including 9,430 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 934 hom., cov: 32)
Exomes 𝑓: 0.11 ( 8496 hom. )

Consequence

COL6A3
NM_004369.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.520

Publications

6 publications found
Variant links:
Genes affected
COL6A3 (HGNC:2213): (collagen type VI alpha 3 chain) This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]
COL6A3 Gene-Disease associations (from GenCC):
  • Bethlem myopathy 1A
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1C
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • dystonia 27
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AR, AD, SD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 2-237348570-C-G is Benign according to our data. Variant chr2-237348570-C-G is described in ClinVar as Benign. ClinVar VariationId is 94974.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.158 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A3NM_004369.4 linkc.6930+43G>C intron_variant Intron 29 of 43 ENST00000295550.9 NP_004360.2 P12111-1D9ZGF2Q8N4Z1Q63HQ4
COL6A3NM_057167.4 linkc.6312+43G>C intron_variant Intron 28 of 42 NP_476508.2 P12111-2Q8N4Z1Q63HQ4
COL6A3NM_057166.5 linkc.5109+43G>C intron_variant Intron 26 of 40 NP_476507.3 P12111-4B7ZW00

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A3ENST00000295550.9 linkc.6930+43G>C intron_variant Intron 29 of 43 1 NM_004369.4 ENSP00000295550.4 P12111-1
COL6A3ENST00000472056.5 linkc.5109+43G>C intron_variant Intron 26 of 40 1 ENSP00000418285.1 P12111-4
COL6A3ENST00000353578.9 linkc.6312+43G>C intron_variant Intron 28 of 42 5 ENSP00000315873.4 P12111-2
COL6A3ENST00000491769.1 linkn.1184+43G>C intron_variant Intron 6 of 19 5

Frequencies

GnomAD3 genomes
AF:
0.108
AC:
16475
AN:
152148
Hom.:
934
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0951
Gnomad AMI
AF:
0.0888
Gnomad AMR
AF:
0.163
Gnomad ASJ
AF:
0.134
Gnomad EAS
AF:
0.0489
Gnomad SAS
AF:
0.119
Gnomad FIN
AF:
0.114
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.105
Gnomad OTH
AF:
0.120
GnomAD2 exomes
AF:
0.115
AC:
27945
AN:
243366
AF XY:
0.114
show subpopulations
Gnomad AFR exome
AF:
0.0946
Gnomad AMR exome
AF:
0.172
Gnomad ASJ exome
AF:
0.129
Gnomad EAS exome
AF:
0.0471
Gnomad FIN exome
AF:
0.117
Gnomad NFE exome
AF:
0.108
Gnomad OTH exome
AF:
0.116
GnomAD4 exome
AF:
0.107
AC:
153857
AN:
1440744
Hom.:
8496
Cov.:
29
AF XY:
0.107
AC XY:
76852
AN XY:
717192
show subpopulations
African (AFR)
AF:
0.0960
AC:
3175
AN:
33062
American (AMR)
AF:
0.172
AC:
7593
AN:
44156
Ashkenazi Jewish (ASJ)
AF:
0.124
AC:
3222
AN:
25958
East Asian (EAS)
AF:
0.0523
AC:
2063
AN:
39476
South Asian (SAS)
AF:
0.119
AC:
10148
AN:
84942
European-Finnish (FIN)
AF:
0.113
AC:
6010
AN:
53146
Middle Eastern (MID)
AF:
0.145
AC:
835
AN:
5746
European-Non Finnish (NFE)
AF:
0.105
AC:
114529
AN:
1094624
Other (OTH)
AF:
0.105
AC:
6282
AN:
59634
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
6908
13815
20723
27630
34538
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4206
8412
12618
16824
21030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.108
AC:
16482
AN:
152266
Hom.:
934
Cov.:
32
AF XY:
0.111
AC XY:
8253
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0950
AC:
3945
AN:
41540
American (AMR)
AF:
0.164
AC:
2504
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.134
AC:
463
AN:
3464
East Asian (EAS)
AF:
0.0488
AC:
253
AN:
5184
South Asian (SAS)
AF:
0.118
AC:
569
AN:
4826
European-Finnish (FIN)
AF:
0.114
AC:
1206
AN:
10610
Middle Eastern (MID)
AF:
0.173
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
0.105
AC:
7159
AN:
68022
Other (OTH)
AF:
0.119
AC:
251
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
747
1495
2242
2990
3737
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0631
Hom.:
94
Bravo
AF:
0.110
Asia WGS
AF:
0.0800
AC:
281
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 38% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 35. Only high quality variants are reported. -

Nov 05, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
7.8
DANN
Benign
0.69
PhyloP100
0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
1.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2646264; hg19: chr2-238257213; COSMIC: COSV107337570; API